id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-N-1112-0001,FDA,FDA-2014-N-1112,"Medical Devices; Clinical Chemistry and Clinical Toxicology Devices;
Classification of Hemoglobin A1c Test System",Rule,Final Rule,2014-08-25T04:00:00Z,2014,8,2014-08-25T04:00:00Z,,2014-08-25T16:33:06Z,2014-20022,0,0,090000648184229c